domingo, 30 de agosto de 2026

A Novartis drug cut inflammation. Can it improve heart outcomes? The drug, pacibekitug, targets IL-6, a common inflammatory driver By Andrew JosephAug. 29, 2026 Europe Correspondent

https://www.statnews.com/2026/08/29/novartis-pacibekitug-inflammation-il6-tourmaline-heart-disease/

No hay comentarios:

Publicar un comentario